I mention this report because I am certain that it would be of interest to at least some of "us". The story includes mention of "XL184", a drug i've been following for awhile now..
http://www.eurekalert.org/pub_releases/2012-02/uoc--ctm022112.php
Here is part of the article...
Cancer therapy more potent when it hits 2 targets
The two-target approach, tested in mice with a type of cancer known as neuroendocrine pancreatic tumors, may have broad application for treating a wide variety of cancers, the UCSF team said. The drugs used in the tests belong to classes of pharmaceuticals that are either on the market or under development in clinical trials.
Clinical trials also are already underway to gauge effectiveness of the approach in humans with prostate cancer, breast cancer, and other tumor types. The UCSF study, described in the journal Cancer Discovery this week, is the first to show how the drug combination works in the laboratory.
The results are promising, said Donald McDonald, MD, PhD, a member of the UCSF Helen Diller Comprehensive Cancer Center and the Cardiovascular Research Institute and professor of anatomy, who led the research.
http://www.eurekalert.org/pub_releases/2012-02/uoc--ctm022112.php
Good thoughts to all of you!